Gordon S Howarth Selected Research

Mucositis

1/2020	Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer.
12/2019	Prebiotics Fructo-, Galacto-, and Mannan-Oligosaccharide Do Not Protect against 5-Fluorouracil-Induced Intestinal Mucositis in Rats.
9/2019	Use of the Rat Grimace Scale to Evaluate Visceral Pain in a Model of Chemotherapy-Induced Mucositis.
3/2019	Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis.
1/2018	A Judgement Bias Test to Assess Affective State and Potential Therapeutics in a Rat Model of Chemotherapy-Induced Mucositis.
1/2018	Intestinal homeostasis is restored in mice following a period of intestinal growth induced by orally administered Emu Oil.
11/2017	Effects of commercially produced almond by-products on chemotherapy-induced mucositis in rats.
2/2017	Effects of Supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on Intestinal Epithelial Cells and a Rat Model of 5-Fluorouracil-Induced Mucositis.
10/2016	Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis.
10/2016	Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gordon S Howarth Research Topics

Disease

41	Mucositis 01/2020 - 05/2003
23	Neoplasms (Cancer) 01/2022 - 07/2003
21	Colitis 01/2022 - 08/2005
18	Inflammation (Inflammations) 01/2021 - 04/2005
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2012 - 07/2003
7	Colitis-Associated Neoplasms 01/2022 - 01/2018
7	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2020 - 07/2003
7	Ulcerative Colitis 03/2019 - 06/2009
6	Colonic Neoplasms (Colon Cancer) 01/2015 - 06/2006
5	Body Weight (Weight, Body) 12/2019 - 06/2003
4	Colorectal Neoplasms (Colorectal Cancer) 03/2019 - 10/2006
4	Arthritis (Polyarthritis) 05/2012 - 04/2005
2	Pain (Aches) 09/2019 - 01/2016
2	Short Bowel Syndrome 04/2010 - 04/2009
2	Intestinal Diseases (Diseases, Intestinal) 04/2010 - 04/2009
2	Enteritis 04/2009 - 07/2003
2	Stomach Neoplasms (Stomach Cancer) 07/2007 - 06/2006
1	Obesity 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	AIDS-Related Complex (ARC) 12/2020
1	Crohn Disease (Crohn's Disease) 12/2020
1	Visceral Pain 09/2019
1	Dysbiosis 01/2016
1	Ileal Diseases 01/2015
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2012
1	Metabolic Bone Diseases (Osteopenia) 06/2012
1	Osteoporosis 06/2012
1	Adenocarcinoma 07/2011
1	Type 2 Diabetes Mellitus (MODY) 11/2009
1	Multiple Sclerosis 11/2009
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 05/2009

Drug/Important Bio-Agent (IBA)

21	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 02/2005
15	emu OilIBA 01/2022 - 08/2010
11	Dextran SulfateIBA 01/2018 - 04/2005
7	PrebioticsIBA 12/2019 - 10/2006
6	Sucrose (Saccharose)IBA 01/2021 - 01/2006
6	Drinking WaterIBA 04/2013 - 03/2007
5	Peroxidase (Myeloperoxidase)IBA 01/2021 - 04/2005
5	Grape Seed ExtractIBA 01/2021 - 02/2009
5	SodiumIBA 01/2021 - 02/2007
5	Dextrans (Dextran)FDA Link 01/2021 - 02/2007
5	Methotrexate (Mexate)FDA LinkGeneric 08/2013 - 05/2003
4	17-hydroxyestrane-3-carbonitrile (ECN)IBA 02/2017 - 04/2011
3	AzoxymethaneIBA 01/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2006
3	OligosaccharidesIBA 12/2019 - 01/2008
3	Pharmaceutical PreparationsIBA 01/2019 - 05/2012
3	Butyrates (Butyrate)IBA 01/2012 - 06/2006
3	Volatile Fatty AcidsIBA 01/2012 - 06/2006
3	EnzymesIBA 08/2010 - 10/2006
3	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 08/2010 - 01/2006
3	Insulin-Like Growth Factor I (IGF-1)IBA 04/2010 - 07/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2010 - 05/2003
2	Opioid Analgesics (Opioids)IBA 09/2019 - 01/2016
2	Analgesics (Analgesic Drugs)IBA 01/2018 - 01/2016
2	OilsIBA 10/2016 - 02/2008
2	Therapeutic UsesIBA 01/2014 - 08/2010
2	Proanthocyanidins (Procyanidins)IBA 01/2014 - 02/2009
2	iberogastIBA 01/2014 - 05/2009
2	AnthracyclinesIBA 08/2013 - 09/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2013 - 09/2006
2	PropionatesIBA 01/2012 - 07/2007
2	Fibroblast Growth Factor 7 FDA Link 09/2011 - 04/2010
2	ZincIBA 09/2009 - 05/2003
2	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 05/2009 - 05/2009
2	lyprinolIBA 02/2008 - 04/2005
1	sairei-toIBA 06/2021
1	High Fructose Corn SyrupIBA 01/2021
1	fluorescein isothiocyanate dextranIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 12/2020
1	Sulfonic AcidsIBA 12/2020
1	MannansIBA 12/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2019
1	Olive OilIBA 10/2016
1	carprofen FDA Link 01/2016
1	NucleotidesIBA 01/2015
1	Plant Preparations (Preparation, Plant)IBA 01/2014
1	AntimetabolitesIBA 08/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2013
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2013
1	CateninsIBA 07/2012
1	Croton OilIBA 05/2012
1	Cystine (L-Cystine)IBA 03/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	CarbonIBA 04/2011
1	Messenger RNA (mRNA)IBA 08/2010
1	Glucagon-Like Peptide 2IBA 04/2010
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2009
1	CytokinesIBA 11/2009
1	antineoplaston A10 (A 10)IBA 09/2009
1	MetallothioneinIBA 09/2009
1	Biomarkers (Surrogate Marker)IBA 05/2009
1	N-sulfoglucosamine sulfohydrolase (sulfamidase)IBA 05/2009

Therapy/Procedure

36	Drug Therapy (Chemotherapy) 01/2020 - 05/2003
13	Therapeutics 09/2019 - 01/2006
2	Oral Administration 01/2018 - 05/2003
2	Intraperitoneal Injections 10/2016 - 03/2007
2	Chemoprevention 01/2015 - 10/2006
1	Kampo Medicine (Kampo) 01/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2014